# Peripheral Immunomarker Validation in Treatment-resistant Depression

> **NCT02752178** · — · COMPLETED · sponsor: **University of Cambridge** · enrollment: 393 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **OTHER:** MA
- **OTHER:** DEP

## Key facts

- **NCT ID:** NCT02752178
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 393 (ACTUAL)
- **Last updated:** 2018-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752178, "Peripheral Immunomarker Validation in Treatment-resistant Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02752178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*